undefined undefined undefined

Pathophysiology of obesity in heart failure

Event: ESC Congress 2025

Topic: Chronic Heart Failure

Session: The new dangerous liaison: obesity and heart failure

Access

Like

Yet more promise for GLP-1 agonists in HFpEF?

Event: ESC Congress 2024

Topic: Treatment

Session: Heart failure: recent breakers

Access

Like

In patients with unexplained dyspnea and preserved left ventricular ejection fraction CPETecho is a useful tool to establish the cause of dyspnea

Event: Heart Failure 2023

Topic: Imaging

Session: Chronic heart failure - imaging 1

Access

Like

Sexual dimorphism in heart failure: targeting the sex-specific fibrotic response

Event: Heart Failure 2023

Topic: Heart Failure

Session: ePosters in basic science 2

Access

Like

Male heart failure with reduced ejection fraction versus female heart failure with preserved ejection fraction: the role of sex-specific responses to common stressors in heart failure development

Event: Heart Failure 2022

Topic: Experimental Heart Failure

Session: Pathophysiology in chronic heart failure: novel pathways

Access

Like

Sex-related differences in inflammation-associated biomarkers and their predictive utility for new-onset heart failure

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Like

Do inflammation-associated biomarkers differ between men and women in prediction of new-onset heart failure ?

Event: Heart Failure 2018

Topic: Clinical, Other

Session: Chronic Heart Failure - Clinical

Access

Like

NPA7, an innovative multivalent designer natriuretic peptide: Co-therapy with Furosemide to mediate renoprotection in experimental ADHF

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (therapy)

Session: Rapid Fire 1 - Basic Science

Access

Like

undefined undefined undefined

Contributor content

Pathophysiology of obesity in heart failure

Yet more promise for GLP-1 agonists in HFpEF?

In patients with unexplained dyspnea and preserved left ventricular ejection fraction CPETecho is a useful tool to establish the cause of dyspnea

Sexual dimorphism in heart failure: targeting the sex-specific fibrotic response

Male heart failure with reduced ejection fraction versus female heart failure with preserved ejection fraction: the role of sex-specific responses to common stressors in heart failure development

Sex-related differences in inflammation-associated biomarkers and their predictive utility for new-onset heart failure

Do inflammation-associated biomarkers differ between men and women in prediction of new-onset heart failure ?

NPA7, an innovative multivalent designer natriuretic peptide: Co-therapy with Furosemide to mediate renoprotection in experimental ADHF

ESC 365 is supported by